Development and Validation of a Disability Severity Index for CMT — 6604

Charcot Marie Tooth Disease Clinical Trial

Official title:
Development and Validation of a Disability Severity Index for Charcot Marie Tooth Disease

Status Completed

Clinical Trial Summary

It is necessary for outcome measures to accurately reflect the state of health of a person in order for clinical trials to show benefit. The most commonly used outcome measure for Charcot Marie Tooth Disease (CMT) is the CMT Neuropathy Score, which uses cutoffs of points designated as mild (0-10 points), moderate (11-20) or severe (21-36). These terms are arbitrary. This study is looking to base mild, moderate, and severe on what both people affected with CMT and those who provide for people with CMT consider appropriate.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01455623
Study type	Observational
Source	University of Iowa
Contact
Status	Completed
Phase	N/A
Start date	June 2011
Completion date	March 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02561702` - Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease	Phase 2
Completed	`NCT00541164` - Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease	Phase 1/Phase 2
Recruiting	`NCT01918826` - Evaluation of the Analgesic Efficiency of the Transcutaneous Neurostimulation in the Charcot Syndrome Marie Tooth on the Pains of Lower Limbs	N/A
Completed	`NCT02194010` - Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
Recruiting	`NCT01203085` - Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Recruiting	`NCT01193075` - Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others